Abstract P4-06-05: Telehealth and cancer care delivery: Evaluating the impact of telehealth on patient access and treatment utilization at a comprehensive cancer center using real world data
Lists
Only you see this
Abstract
Abstract introduction: Telehealth has persisted post-COVID 19 due to its convenience, potential to improve access to care, and changes in telehealth reimbursement incentivizing its use. Data are needed to examine telehealth’s impact on care utilization and patient (pt) access among diverse cancer types to inform long-term telehealth policies. Methods: We used a deidentified clinical data warehouse to develop 2 cohorts of pts treated at our center from 2017-2019 (pre-telehealth) and 2021-2023 (post-telehealth). Data from 2020 was excluded, given peak pandemic irregularities. We included pts ≥18 yrs who completed ≥1 medical, surgical or radiation oncology visit with an associated cancer diagnosis. We strategically selected 3 disease groups with varying telehealth use: breast (low), GI (medium), GU (high). This allowed us to control for external factors (eg COVID) and better isolate the impact of telehealth. We obtained pt data (age, sex, race, zip code), visit data (new/follow-up, in-person/video, provider, department) and identified pts receiving cancer treatment (tx) at our center. We compared changes in visit distribution, sociodemographics, and tx patterns within and between disease groups pre- and post-telehealth using Chi-square and ANOVA tests. Results: A total of 102,516 encounters and 25,123 pts pre-telehealth vs 139,309 encounters and 47,814 pts post-telehealth were analyzed. The # of unique pts seen pre- and post-telehealth increased significantly in all groups (+101% breast, +60% GI, +108% GU). Post-telehealth, the proportion of video visits (VVs) increased in breast from 1.6% to 28.2%, with most visits remaining in-person (IP; 71.5%); GI increased VVs from 1.9% to 55.3% of total visits; GU increased VVs from 3.1% to 81.4%. The distribution of visits by department, visit and provider type were similar pre- and post-telehealth for all groups. Among all groups, the proportion of pts identifying as White decreased among aggregated visit types, while the proportion of Asian and LatinX pts increased post-telehealth. In breast and GU, there was a statistically significant change in the geographic distribution of pts post-telehealth, with an increase in unique pts seen who lived in San Francisco (+7.4% breast, +3.5% GU). Post-telehealth, the % of pts who received radiation increased in breast, GI, and GU (+3.7, +2.3, +1.3). In breast and GI, the % of pts receiving infusions increased (+3.4, +1.6), but decreased in GU (-0.6). The % of pts who underwent surgery decreased among all groups (-6.6, -4.4, -6.7). Discussion: We evaluated 3 oncology disease-based groups with varying telehealth use to characterize the impact of widespread telehealth adoption on pt demographics and tx patterns. Total pts seen increased in all 3 groups. Notably, more pts with breast and GU cancer were seen from San Francisco post-telehealth. Given similar increases in pt volume and geographic shifts between low and high telehealth groups, this cannot be attributed to telehealth alone. Additional analyses to characterize telehealth’s impact on pt access are ongoing. Regarding tx, the % of pts receiving infusions and radiation increased most in breast, which maintained the highest % of IP visits, highlighting the importance of IP visits during active tx. Limitations of our study include an inability to capture whether pts were seen via telehealth for 2nd opinions and treated locally or pts who received oral medications. This will be explored in future analyses. Study strengths include the large sample size and study design that leverages differences in telehealth use among disease groups to better isolate telehealth’s impact on care patterns and pt demographics. Overall, we observed significant increases in pt volume and shifts in geographic distribution post-telehealth. Further analyses will be reported. Citation Format: Kelsey Natsuhara, Hope S. Rugo, Sorbarikor Piawah, Jean Feng, Travis Zack, Jie Jane Chen, Nathan Magalit, Ryzen Benson, Anobel Odisho, Alan P. Venook, Julian C. Hong. Telehealth and cancer care delivery: Evaluating the impact of telehealth on patient access and treatment utilization at a comprehensive cancer center using real world data [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2024; 2024 Dec 10-13; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(12 Suppl):Abstract nr P4-06-05.
BibTeX
@inproceedings{natsuhara2025abstract,
author = {Kelsey Natsuhara and Hope S. Rugo and Sorbarikor Piawah and Jean Feng and Travis Zack and Jie Jane Chen and Nathan Magalit and Ryzen Benson and Anobel Y. Odisho and Alan P. Venook and Julian C. Hong},
title = {{Abstract P4-06-05: Telehealth and cancer care delivery: Evaluating the impact of telehealth on patient access and treatment utilization at a comprehensive cancer center using real world data}},
booktitle = {Clinical},
year = {2025},
doi = {10.1158/1557-3265.sabcs24-p4-06-05},
}Loading related content...